Julie H. Jun
Clinical Assistant Professor, College of Medicine - Ambulatory Care
Clinical Pharmacy Specialist, Ambulatory Care, Pharmacy
Email:
Related Sites:
About Heading link
Teaching and Supervision Heading link
PDAT 5: Cardiovascular (PHAR 505), 1/9/2023 – 4/28/2023
PDAT 5: Cardiovascular (PHAR 505), 1/9/2023 – 4/28/2023
PDAT 5: Cardiovascular (PHAR 505), 1/9/2023 – 4/28/2023
PDAT 5: Cardiovascular (PHAR 505), 1/9/2023 – 4/28/2023
PDAT 5: Cardiovascular (PHAR 505), 1/9/2023 – 4/28/2023
PDAT 10: Principles of Drug Action and Therapeutics (PHAR 510), 4/11/2022 – 5/2/2022
PDAT 5: Cardiovascular (PHAR 505), 1/10/2022 – 4/29/2022
PDAT 5: Cardiovascular (PHAR 505), 1/10/2022 – 4/29/2022
PDAT 5: Cardiovascular (PHAR 505), 1/10/2022 – 4/29/2022
Selected Grants
CONTAIN COVID-19: Convalescent plasma to limit Coronavirus associated complications: A randomized blinded phase 2 study comparing the efficacy and safety of anti-SARS-COV-2 plasma to placebo in COVID-19 hospitalized patient, New York University Langone Health., 11/23/2020 - 3/15/2021, No Obligated Amount Set; No Anticipated Amount Set
CONTAIN COVID-19: Convalescent plasma to limit Coronavirus associated complications: A randomized blinded phase 2 study comparing the efficacy and safety of anti-SARS-COV-2 plasma to placebo in COVID-19 hospitalized patient, New York University Langone Health., 11/1/2020 - 3/15/2021, No Obligated Amount Set; No Anticipated Amount Set
Health Promoters and Pharmacists in Diabetes Team Management, NIH/NIDDK., 2015 - 2017, Obligated Amount: $1707855; Anticipated Amount: $1707855
Professional Leadership
Geriatric Care Expert Toolkit App, 3/1/2017 - 3/1/2017
Rush University Pharmacy Departmental Transformation Committee, 2014 - 2015
Education & Drug Utilization Evaluation Committee, 2010 - 2015
Residency Advisory Committee, 2010 - 2015
Licensures and Certifications
Board Certified Pharmacotherapy Specialist (BCPS), American College of Clinical Pharmacy, 10/3/2009 - Present